UK Study on frequency of non-conformities during routine biomarker testing

3 months ago

UK Study to evaluate the frequency of non-conformities during routine biomarker testing for lung and colon cancer

For information:

Laboratories are invited to participate in a study to evaluate the frequency of non-conformities during routine biomarker testing for lung and colon cancer. The aim of this study is to benchmark different non-conformities between institutes in the UK, and to compare them with data that has already been collected from other European institutes.

All data will be handled anonymously and will be included in a Biomedical Science final year project and a further PhD thesis, as a joint initiative between the University of Leuven in Belgium under the supervision of Prof. Dequeker and the Queen Elizabeth Hospital Birmingham (QEHB), UK under the supervision of Mr. Brendan O’Sullivan.

The completion of the questionnaire will take no more than 15 minutes of your time. To start the survey please CLICK HERE.

We hope that we can gather representative data from all over the UK and would greatly appreciate it if you would take part in this study.

Please do not hesitate to contact the study authors with any questions you might have.

  • Yann van Royen, Biomedical Science student at University of Leuven, Belgium
  • Mr. Brendan O’Sullivan, Operations Manager in Molecular Pathology at QEHB
  • Dr. Philippe Taniere, Consultant Histopathologist at QEHB
  • Cleo Keppens, PhD student,Biomedical Quality Assurance Research Unit at KU Leuven Belgium
  • Prof Dequeker, Head of Biomedical Quality Assurance Research Unit at KU Leuven Belgium

Next: IQN Path looking for new Independent Director